A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma
一项评估 CHK1 抑制剂 LY2880070 与低剂量吉西他滨联合治疗转移性胰腺腺癌患者的安全性和有效性的 I 期扩展队列研究
期刊:Clinical Cancer Research
影响因子:10
doi:10.1158/1078-0432.CCR-23-2005
Brandon M Huffman, Hanrong Feng, Kalindi Parmar, Junning Wang, Kevin S Kapner, Bose Kochupurakkal, David B Martignetti, Golbahar Sadatrezaei, Thomas A Abrams, Leah H Biller, Marios Giannakis, Kimmie Ng, Anuj K Patel, Kimberly J Perez, Harshabad Singh, Douglas A Rubinson, Benjamin L Schlechter, Eliza